Dr. Payal Urvij Modhia, MD

Dr. Modhia practices at Presbyterian Hospital in Albuquerque, New Mexico, part of Presbyterian Healthcare Services.

Dr. Modhia's NPI, 1083961072, was assigned on August 8, 2012. Dr. Modhia holds Illinois license 125061482.

Dr. Modhia's primary practice is Presbyterian Hospital, at 1100 Central Avenue SE, Albuquerque, NM 87106 in Bernalillo County. The practice phone is (505) 724-8386.

Dr. Modhia's primary practice is Presbyterian Hospital in Albuquerque, New Mexico, part of Presbyterian Healthcare Services. Dr. Modhia is also affiliated with University of New Mexico Hospital. The medical group on file is Presbyterian Medical Group. Dmand AI also links Dr. Modhia to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Modhia practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Modhia's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Modhia's licenses on file in 2 states: Illinois and New Mexico.

CMS data shows 598 Medicare services from Dr. Modhia across 7 procedure codes in 2024, for 197 Medicare patients. Medicare paid $40,400 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 197 Medicare patients who saw Dr. Modhia in 2024. The largest group is 75 to 84, with 75 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 32% are also on Medicaid. Their average risk score is 2.46, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Modhia's median patient age at 63, with 49% women.

In 2024, Dr. Modhia wrote 625 Medicare Part D claims for 166 patients. 83% of them were for generic drugs. CMS names the drug for 339 of them, across 18 drugs with 11 or more claims each, at $23,774 in total drug cost. In 2023, CMS named 192 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Modhia for performance year 2024, reported as part of a group. Dr. Modhia accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 4 general payments to Dr. Modhia from 2 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Stryker Corporation paid the most, $48.